Blue Biotechnology Market Research Report - Global Forecast to 2027

Blue Biotechnology Market, by Product (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers), by Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery, Others), by End-Users (Hospitals, Labs) – Forecast Till 2027

ID: MRFR/HC/0242-HCR | February 2021 | Region: Global | 80 pages

Blue Biotechnology Market Scenario:


The blue biotechnology market is relied upon to develop altogether during the conjecture time frame (2017–2023).


The blend of science and innovation to foster new items utilized in agribusiness, the climate, and others is called biotechnology. Cells and cell parts, living beings are utilized for the progression of innovation to work on personal satisfaction. The blend of oceanic and marine life forms with innovation to benefit new wellsprings of energy, foster new medications, extricate new dynamic fixings, or simply increment fish creation and its well-being recalled use biotechnology. It is worried about making new marine innovations, the investigation of marine organic entities to screen the ocean climate, and wellbeing dangers to people. Blue biotechnology is useful in the determination of sicknesses through microbial testing of microorganisms. It has wide application in the field of life science and medical services. Blue biotechnology feels like a moving field since it is flexible, versatile, and ceaselessly pushing ahead.


The utilizations of blue biotechnology are expanding step by step with the assistance of high throughput screening and genomics which is applied to tap the variety of the sea. Tapped assets from seas are used for different purposes like treatment of the AIDS infection, beauty care products, and the drug area. The blue biotechnology market is developing quickly and is projected to ascend in forthcoming years because of an expansion sought after for hereditarily adjusted microorganisms. Factors like creating amphibian sustainable power, the sea-going innovation utilized for observing the ocean environment support the blue biotechnology market. Protecting marine life from the contamination brought about by humanity is the major limiting element for the developing business sector.


COVID-19 Analysis


The WHO has articulated the eruption of the COVID-19 contamination as an overall prosperity emergency following its occasion in December 2019. More than 100 countries throughout the planet have been impacted by the disorder, which has caused a ton of deaths. A ton of mischief has been caused to the overall collecting, the movement business, and cash organizations. Lately, the plummeting strain on the world economy has extended again after previously giving signs of recovery. A plague scene has added perilous parts to the world economy, which was by then doing combating. It has been noted by various overall affiliations that the financial crisis has left the world economy in its most debilitating state.


Market Dynamics


The flooding revenue for normal things overproduced things across the globe is one of the essential issues inciting the advancement of the blue biotechnology market. Rising assessment and improvement activities and use are inciting liberal augmentation of progression in the field of blue biotechnology. Subsequently, it is supporting the improvement of the market. The growing availability of different blue biotechnology things in various undertakings is similarly driving the improvement of the market. Filling revenue for things like various prescriptions, medications, and remedial things in the excellence care items and medication adventures are growing the premium for blue biotechnology which is driving the improvement of the market. The rising gathering of non-standard prescriptions over traditional meds for the treatment of illnesses, for instance, is helping the advancement of the market. Growing drives taken by the public power and NGOs across the globe to prevent marine and the maritime natural framework has introduced various intense standards and rules which is restricting the advancement of the blue biotechnology market.


Technology Analysis


Biotechnology is characterized as innovation using living organic entities to foster different items to foster new wellsprings of biofuel, creating antibodies, against maturing beauty care products, larger blending, and hereditary alteration of harvests. Blue biotechnology, a blend of innovation and marine and amphibian life forms, is significantly used to foster new energy sources.


Drug enterprises are most broadly utilizing blue innovation for the fix of different infections. Furthermore, the expanding interest for clients to utilize blue innovation drugs is one of the essential components helping the development of the market.


Because of its use, the blue biotechnology market is separated into drug revelation, antibody advancement, genomics, and bio-designing. Immunization advancement applications hold a lot of portions of the overall industry. Blue innovation is utilized for immunization advancement as a prudent step forever taking infections. The development of the market for the application is ascribed to regular constituents and less incidental effects because of the utilization of blue innovation antibodies.


Market Segmentation


There are three segments in the market: products, applications, and end-users.


Among the market's categories, enzymes, bulk chemicals, biopolymers, and pharma products are included.


Bioengineering, genomics, vaccine development, drug discovery, and others comprise the market based on application.


According to end-users, the market has been classified as hospitals, pharmaceutical companies, biotechnology companies, research institutes, and laboratories.


There are four geographic segments of the market: Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas have been further divided into North America and South America, with the North American market separating into the United States and Canada.


Western Europe and Eastern Europe make up the two segments of the European blue biotechnology market. Moreover, Western Europe has been further divided into Germany, France, the UK, Italy, Spain, and other Western European countries.


Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific are among the countries segmented by the blue biotechnology market in Asia-Pacific. Several segments of the Middle East & Africa blue biotechnology market have been identified.


Blue Biotechnology Market, by Products



  • Enzymes

  • Pharma Products

  • Bulk Chemicals

  • Biopolymers

  • Others


Blue Biotechnology Market, by Application



  • Bioengineering

  • Genomics

  • Vaccine Development

  • Drug Discovery

  • Others


Blue Biotechnology Market, by End-Users



  • Hospitals

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Research Institutes

  • Laboratories

  • Others


Blue Biotechnology Market, by Region


North America



  • US

  • Canada

  • South America


Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea


Rest of Asia-Pacific



  • The Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Biotechnology Companies

  • Biotechnology Research Centers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Academic Medical Institutes and Universities


Regional Analysis


Blue biotechnology market share is expected to be dominated by North America during the forecast period, due to the increasing public awareness and the rising demand for these products in the vaccine development field.


This market is fueled by the presence of numerous biotechnology companies conducting research and development activities in blue biotechnology, the fact that cosmetic manufacturers are becoming more interested in aquatic biotechnology, and the increase in applications such as cosmetics, pharmaceuticals, and others.


The European market will have the second-highest share of the global market. The European region has seen the growth of the blue biotechnology market boosted by the increasing focus on marine technology for drug discovery and development.


As the application of blue biotechnology in various fields is still relatively limited in Asia-Pacific, the market share in this region shows a sturdy growth. There is a lack of awareness about the use of microorganisms in the marine environment and their applications in the region, thus slowing the market.


As a result of an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities, the Middle East & Africa is expected to have the smallest share of the blue biotechnology market.


Competitive Landscape


The blue biotechnology market is tolerably divided attributable to the presence of a few market players. The wide scope of business utilization of blue biotechnology will increase market development. This statistical surveying report will assist customers with distinguishing new development openings and plan extraordinary development techniques by giving an extensive examination of the market's serious scene and offering data on the items presented by organizations.


Several companies dominate the blue biotechnology market, including Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (US), PML Applications Ltd. (UK), Sea Run Holdings, Inc. (the US), PICES (Canada), Donald Danforth Plant Science Center (US), Shell Marine Products (US), GeoMarine Biotechnologies (India), GlycoMar (Scotland), Cellgen Biologicals Pvt Ltd. (India), Nurture Aqua Technology Pvt. Ltd. (India), Samudra Biopharma Pvt. Ltd (India), and Sanosil Biotech (India).


Recent Developments


Blue biotechnology is the utilization of subatomic natural strategies to marine and freshwater life forms. These creatures are utilized for purposes like expanding fish supply and security, controlling the generation of perilous water-borne living beings, and growing new medications.


Report


Worldwide "Blue Biotechnology Market" report gives size development rate investigation by type, utilization examination by application, business procedure, income gauges, key organizations, fabricating cost examination. Additionally, the Blue Biotechnology market incorporates share by producers, fabricating cost structure, modern chain investigation, advancement, elements, market breakdown, information triangulation, and Covid-19 effect is canvassed in this report.


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Factors like the evolving aquatic technology for monitoring of sea atmosphere and developing aquatic renewable energy would develop the blue biotechnology market.

End user industries like pharmaceutical companies, hospitals, laboratories, biotechnology companies, research institutes, and others would profit from the blue biotechnology market.

North America has the potential to score the most for the blue biotechnology market.

Demand for preserving marine life from man-made pollution can hold back the blue biotechnology market growth.

The blue biotechnology yields products that are used in treating the AIDS virus among many, which can help the blue biotechnology market grow.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Blue Biotechnology Market Information, by Products

6.1 Introduction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2 Enzymes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Pharma Products

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Bulk Chemicals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Biopolymers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Blue Biotechnology Market Information, by Application

7.1 Introduction

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2 Bio-Engineering

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Genomics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Vaccine Development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Drug Discovery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Blue Biotechnology Market Information, by Application

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Biotechnology Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Blue Biotechnology Market Information, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Aker BioMarine

11.1.1 Company Overview

11.1.2 Products Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Marinova

11.2.1 Company Overview

11.2.2 Products Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 New England Biolabs

11.3.1 Company Overview

11.3.2 Products Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 PML Applications Ltd.

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Sea Run Holdings, Inc.

11.5.1 Company Overview

11.5.2 Products Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 PICES

11.6.1 Company Overview

11.6.2 Products Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Donald Danforth Plant Science Center

11.7.1 Overview

11.7.2 Products Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Shell Marine Products

11.8.1 Overview

11.8.2 Products/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 GeoMarine Biotechnologies

11.9.1 Overview

11.9.2 Products Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 GlycoMar

11.10.1 Overview

11.10.2 Products Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Cellgen Biologicals Pvt Ltd

11.11.1 Overview

11.11.2 Products Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Nurture Aqua Technology Pvt. Ltd

11.12.1 Overview

11.12.2 Products Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Samudra Biopharma Pvt. Ltd

11.13.1 Overview

11.13.2 Products Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cryolife, Inc.

11.14.1 Overview

11.14.2 Products Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Sanosil Biotech

11.15.1 Overview

11.15.2 Products Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Biosurgery Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Blue Biotechnology Market Information Synopsis, 2020–2027

Table 2 Global Blue Biotechnology Market Information Estimates and Forecast, 2020- 2027(USD Million)

Table 3 Global Blue Biotechnology Market Information, by Region, 2020- 2027(USD Million)

Table 4 Global Blue Biotechnology Market Information, by Products, 2020- 2027(USD Million)

Table 5 Global Blue Biotechnology Market Information, by Application, 2020- 2027(USD Million)

Table 6 Global Blue Biotechnology Market Information, by End-users, 2020- 2027(USD Million)

Table 7 North America: Blue Biotechnology Market Information, by Products, 2020- 2027(USD

Million)

Table 8 North America: Blue Biotechnology Market Information, by Application, 2020- 2027(USD

Million)

Table 9 North America: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD

Million)

Table 10 US: Blue Biotechnology Market Information, by Products, 2020- 2027(USD Million)

Table 11 US: Blue Biotechnology Market Information, by Application, 2020- 2027(USD Million)

Table 12 US: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD Million)

Table 13 Canada: Blue Biotechnology Market Information, by Products, 2020- 2027(USD Million)

Table 14 Canada: Blue Biotechnology Market Information, by Application, 2020- 2027(USD Million)

Table 15 Canada: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD

Million)

Table 16 South America: Blue Biotechnology Market Information, by Products, 2020- 2027(USD

Million)

Table 17 South America: Blue Biotechnology Market Information, by Application, 2020- 2027(USD

Million)

Table 18 South America: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD

Million)

Table 19 Europe: Blue Biotechnology Market Information, by Products, 2020- 2027(USD Million)

Table 20 Europe: Blue Biotechnology Market Information, by Application, 2020- 2027(USD Million)

Table 21 Europe: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD Million)

Table 22 Western Europe: Blue Biotechnology Market Information, by Products, 2020- 2027(USD

Million)

Table 23 Western Europe: Blue Biotechnology Market Information, by Application, 2020- 2027(USD

Million)

Table 24 Western Europe: Blue Biotechnology Market Information, by End-users, 2020–2027

(USD Million)

Table 25 Eastern Europe: Blue Biotechnology Market Information, by Products, 2020- 2027(USD

Million)

Table 26 Eastern Europe: Blue Biotechnology Market Information, by Application, 2020- 2027(USD

Million)

Table 27 Eastern Europe: Blue Biotechnology Market Information, by End-users, 2020- 2027

(USD Million)

Table 28 Asia-Pacific: Blue Biotechnology Market Information, by Products, 2020- 2027(USD

Million)

Table 29 Asia-Pacific: Blue Biotechnology Market Information, by Application, 2020- 2027(USD

Million)

Table 30 Asia-Pacific: Blue Biotechnology Market Information, by End-users, 2020- 2027(USD

Million)

Table 31 Middle East & Africa: Blue Biotechnology Market Information, by Products, 2020- 2027

(USD Million)

Table 32 Middle East & Africa: Blue Biotechnology Market Information, by Application, 2020- 2027

(USD Million)

Table 33 Middle East & Africa: Blue Biotechnology Market Information, by End-users, 2020- 2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Blue Biotechnology Market Information

Figure 3 Segmentation Market Dynamics for Global Blue Biotechnology Market Information

Figure 4 Global Blue Biotechnology Market Information Share, by Products,

Figure 5 Global Blue Biotechnology Market Information Share, by Application, 2020

Figure 6 Global Blue Biotechnology Market Information Share, by End-users, 2020

Figure 7 Global Blue Biotechnology Market Information Share, by Region, 2020

Figure 8 North America: Blue Biotechnology Market Information Share, by Country, 2020

Figure 9 Europe: Blue Biotechnology Market Information Share, by Country, 2020

Figure 10 Asia-Pacific: Blue Biotechnology Market Information Share, by Country, 2020

Figure 11 Middle East & Africa: Blue Biotechnology Market Information Share, by Country, 2020

Figure 12 Global Blue Biotechnology Market Information: Company Share Analysis, 2020 (%)

Figure 13 Aker BioMarine: Key Financials

Figure 14 Aker BioMarine: Segmental Revenue

Figure 15 Aker BioMarine: Geographical Revenue

Figure 16 Marinova: Key Financials

Figure 17 Marinova: Segmental Revenue

Figure 18 Marinova: Geographical Revenue

Figure 19 New England Biolabs: Key Financials

Figure 20 New England Biolabs: Segmental Revenue

Figure 21 New England Biolabs: Geographical Revenue

Figure 22 PML Applications Ltd: Key Financials

Figure 23 PML Applications Ltd: Segmental Revenue

Figure 24 PML Applications Ltd: Geographical Revenue

Figure 25 Sea Run Holdings, Inc.: Key Financials

Figure 26 Sea Run Holdings, Inc.: Segmental Revenue

Figure 27 Sea Run Holdings, Inc.: Geographical Revenue

Figure 28 PICES: Key Financials

Figure 29 PICES: Segmental Revenue

Figure 30 PICES: Geographical Revenue

Figure 31 Donald Danforth Plant Science Center: Key Financials

Figure 32 Donald Danforth Plant Science Center: Segmental Revenue

Figure 33 Donald Danforth Plant Science Center: Geographical Revenue

Figure 34 Shell Marine Products: Key Financials

Figure 35 Shell Marine Products Segmental Revenue

Figure 36 Shell Marine Products: Geographical Revenue

Figure 37 GeoMarine Biotechnologies: Key Financials

Figure 38 GeoMarine Biotechnologies: Segmental Revenue

Figure 39 GeoMarine Biotechnologies: Geographical Revenue

Figure 40 GlycoMar: Key Financials

Figure 41 GlycoMar: Segmental Revenue

Figure 42 GlycoMar: Geographical Revenue

Figure 43 Cellgen Biologicals Pvt Ltd: Key Financials

Figure 44 Cellgen Biologicals Pvt Ltd: Segmental Revenue

Figure 45 Cellgen Biologicals Pvt Ltd: Geographical Revenue

Figure 46 Nurture Aqua Technology Pvt. Ltd: Key Financials

Figure 47 Nurture Aqua Technology Pvt. Ltd: Segmental Revenue

Figure 48 Nurture Aqua Technology Pvt. Ltd: Geographical Revenue

Figure 49 Samudra Biopharma Pvt. Ltd: Key Financials

Figure 50 Samudra Biopharma Pvt. Ltd: Segmental Revenue

Figure 51 Samudra Biopharma Pvt. Ltd: Geographical Revenue

Figure 52 Sanosil Biotech: Key Financials

Figure 53 Sanosil Biotech: Segmental Revenue

Figure 54 Sanosil Biotech: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.